A Phase I, Open-label, Fixed-sequence Study to Evaluate the Effect of Repeated Subcutaneous Injections of GZR18 Injection on the Pharmacokinetics of Oral Metformin Hydrochloride Tablets in Overweight/Obese Subjects
Latest Information Update: 06 Nov 2024
At a glance
- Drugs Bofanglutide (Primary) ; Metformin
- Indications Obesity
- Focus Pharmacokinetics
- Sponsors Gan&Lee Pharmaceuticals
Most Recent Events
- 06 Nov 2024 New trial record